LOGO
LOGO

Corporate News

Novartis Q2 Results Climb, Top Estimates; Maintains FY21 Outlook - Quick Facts

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Swiss drug major Novartis (NVS) reported Wednesday that its second-quarter net income climbed 55 percent to $2.90 billion from last year's $1.87 billion, driven by momentum of key growth brands.

Earnings per share grew 57 percent to $1.29 from prior year's $0.82.

Core net income was $3.72 billion, compared to $3.11 billion a year ago. Core earnings per share were $1.66, compared to last year's $1.36.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19